-
This Month’s Issue of JUO
- Cheol Kwak
-
J Urol Oncol. 2023;21(2):95-96.
-
Editorial
Jul 31, 2023
|
-
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance
- Chang Wook Jeong
-
J Urol Oncol. 2023;21(2):97-105.
-
Invited Review
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
- Byung Kwan Park
-
J Urol Oncol. 2023;21(2):106-111.
-
Invited Review
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Impact of Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Extension According to the National Comprehensive Cancer Network Risk Stratification in Prostate Cancer
- Jae Hoon Kang, Jun-Koo Kang, Jae-Wook Chung, et al.
-
J Urol Oncol. 2023;21(2):112-120.
-
Topic Article
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
- Jung Sik Huh, Kyung Kgi Park
-
J Urol Oncol. 2023;21(2):121-127.
-
Original Article
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer
- Hyunho Han, Minyong Kang, Seok-Soo Byun, et al.
-
J Urol Oncol. 2023;21(2):128-139.
-
Invited Review
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery?
- Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, et al.
-
J Urol Oncol. 2023;21(2):140-147.
-
Invited Review
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma
- Dongsu Kim, Bumjin Lim, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(2):148-153.
-
Original Article
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
- Sang Hun Song, Jong Jin Oh
-
J Urol Oncol. 2023;21(2):154-164.
-
Invited Review
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis
- Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, et al.
-
J Urol Oncol. 2023;21(2):165-173.
-
Original Article
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
The Predictive Value of the Preoperative Systemic Inflammatory Response Indices in Non–Organ-Confined Disease in Upper Urinary Tract Urothelial Carcinoma
- Sung Kyung Choi, Chan Hoon Gwak, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(2):174-180.
-
Original Article
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|